Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

Director's Buy Signal for Harrow Shares Amid Mixed Financial Reports

A director at Harrow, Inc. recently increased her personal stake in the company by purchasing 1,000 shares. This insider activity occurs against a backdrop of mixed financial news for the firm, which reported first-quarter results that missed analyst expectations. The transaction takes place while the stock is trading near the purchase price but re…

Cybersecurity Executive Sells Shares in CrowdStrike Amid Positive Analyst Coverage and Product Expansion

Cybersecurity Executive Sells Shares in CrowdStrike Amid Positive Analyst Coverage and Product Expansion

CrowdStrike CEO George Kurtz sold Class A common stock totaling $1.47 million on May 15, 2026, executing the trades under a pre-arranged 10b5-1 plan. This activity occurred while the company experienced recent strong gains and saw analysts raise price targets. Concurrently, CrowdStrike launched new products like Jet and Falcon OverWatch for Defende…

Director Sells Shares While Acquiring Options at Mirum Pharmaceuticals; Company Announces Strategic Financing

Director Sells Shares While Acquiring Options at Mirum Pharmaceuticals; Company Announces Strategic Financing

Mirum Pharmaceuticals' director, Saira Ramasastry, executed a complex transaction involving the sale of common stock shares alongside the acquisition of new shares via vested options. This activity occurred against a backdrop of recent Q1 2026 earnings that saw strong revenue growth but disappointing EPS figures due to one-time expenses. Furthermor…

BioCardia CEO Peter Altman's Stock Purchase Amid Market Downturn

BioCardia CEO Peter Altman's Stock Purchase Amid Market Downturn

Peter Altman, President and CEO of BioCardia, Inc., recently acquired a block of the company's common stock. This insider transaction occurs while the stock is trading near its 52-week low. Separately, the company reported first-quarter 2026 earnings, detailing operational improvements and focusing on advancing its CardiAMP cell therapy program whi…

Director Jarrod Patten Executes Significant Stock Sale at Strategy Inc; Analyst Ratings and Bitcoin Volatility Remain Key Focus Areas

Director Jarrod Patten Executes Significant Stock Sale at Strategy Inc; Analyst Ratings and Bitcoin Volatility Remain Key Focus Areas

Jarrod M. Patten, a director at Strategy Inc (NASDAQ:MSTR), recently sold 1,500 shares of Class A Common Stock following the exercise of stock options. The transaction occurred after the company reported its first-quarter 2026 earnings, which included a substantial mark-to-market loss on Bitcoin holdings. Despite this financial report, major invest…